Search Results - "Zulli, Allison" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779

A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779

by Dugan, Benjamin J, Gingrich, Diane E, Mesaros, Eugen F, Milkiewicz, Karen L, Curry, Matthew A, Zulli, Allison L, Dobrzanski, Pawel, Serdikoff, Cynthia, Jan, Mahfuza, Angeles, Thelma S, Albom, Mark S, Mason, Jennifer L, Aimone, Lisa D, Meyer, Sheryl L, Huang, Zeqi, Wells-Knecht, Kevin J, Ator, Mark A, Ruggeri, Bruce A, Dorsey, Bruce D
Published in Journal of medicinal chemistry (14.06.2012)

Get full text

Journal Article

Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent

by Hudkins, Robert L, Becknell, Nadine C, Zulli, Allison L, Underiner, Ted L, Angeles, Thelma S, Aimone, Lisa D, Albom, Mark S, Chang, Hong, Miknyoczki, Sheila J, Hunter, Kathryn, Jones-Bolin, Susan, Zhao, Hugh, Bacon, Edward R, Mallamo, John P, Ator, Mark A, Ruggeri, Bruce A
Published in Journal of medicinal chemistry (26.01.2012)

Get full text

Journal Article

The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity

The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity

by Miknyoczki, Sheila, Chang, Hong, Grobelny, Jennifer, Pritchard, Sonya, Worrell, Candace, McGann, Natalie, Ator, Mark, Husten, Jean, Deibold, James, Hudkins, Robert, Zulli, Allison, Parchment, Ralph, Ruggeri, Bruce
Published in Molecular cancer therapeutics (01.08.2007)

Get full text

Journal Article

Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists

Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists

by Zulli, Allison L., Aimone, Lisa D., Mathiasen, Joanne R., Gruner, John A., Raddatz, Rita, Bacon, Edward R., Hudkins, Robert L.
Published in Bioorganic & medicinal chemistry letters (15.04.2012)

Get full text

Journal Article

4-Phenoxypiperidine pyridazin-3-one histamine H3 receptor inverse agonists demonstrating potent and robust wake promoting activity

4-Phenoxypiperidine pyridazin-3-one histamine H3 receptor inverse agonists demonstrating potent and robust wake promoting activity

by Hudkins, Robert L., Zulli, Allison L., Dandu, Reddeppa reddy, Tao, Ming, Josef, Kurt A., Aimone, Lisa D., Curtis Haltiwanger, R., Huang, Zeqi, Lyons, Jacquelyn A., Mathiasen, Joanne R., Raddatz, Rita, Gruner, John A.
Published in Bioorganic & medicinal chemistry letters (15.02.2012)

Get full text

Journal Article

8-THP-DHI analogs as potent Type I dual TIE-2/VEGF-R2 receptor tyrosine kinase inhibitors

8-THP-DHI analogs as potent Type I dual TIE-2/VEGF-R2 receptor tyrosine kinase inhibitors

by Hudkins, Robert L., Zulli, Allison L., Underiner, Ted L., Angeles, Thelma S., Aimone, Lisa D., Meyer, Sheryl L., Pauletti, Daniel, Chang, Hong, Fedorov, Elena V., Almo, Steven C., Fedorov, Alexander A., Ruggeri, Bruce A.
Published in Bioorganic & medicinal chemistry letters (01.06.2010)

Get full text

Journal Article

4,5-Dihydropyridazin-3-one derivatives as histamine H3 receptor inverse agonists

4,5-Dihydropyridazin-3-one derivatives as histamine H3 receptor inverse agonists

by Hudkins, Robert L., Aimone, Lisa D., Dandu, Reddeppa reddy, Dunn, Derek, Gruner, John A., Huang, Zeqi, Josef, Kurt A., Lyons, Jacquelyn A., Mathiasen, Joanne R., Tao, Ming, Zulli, Allison L., Raddatz, Rita
Published in Bioorganic & medicinal chemistry letters (01.01.2012)

Get full text

Journal Article

Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity

Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity

by Hudkins, Robert L., Aimone, Lisa D., Bailey, Thomas R., Bendesky, Robert J., Dandu, Reddeppa reddy, Dunn, Derek, Gruner, John A., Josef, Kurt A., Lin, Yin-Guo, Lyons, Jacquelyn, Marcy, Val R., Mathiasen, Joanne R., Sundar, Babu G., Tao, Ming, Zulli, Allison L., Raddatz, Rita, Bacon, Edward R.
Published in Bioorganic & medicinal chemistry letters (15.09.2011)

Get full text

Journal Article

Novel C-3 N-urea, amide, and carbamate dihydroindazolo[5,4- a]pyrrolo[3,4- c]carbazole analogs as potent TIE-2 and VEGF-R2 dual inhibitors

Novel C-3 N-urea, amide, and carbamate dihydroindazolo[5,4- a]pyrrolo[3,4- c]carbazole analogs as potent TIE-2 and VEGF-R2 dual inhibitors

by Becknell, Nadine C., Zulli, Allison L., Angeles, Thelma S., Yang, Shi, Albom, Mark S., Aimone, Lisa D., Robinson, Candy, Chang, Hong, Hudkins, Robert L.
Published in Bioorganic & medicinal chemistry letters (15.10.2006)

Get full text

Journal Article

Design and synthesis of dihydroindazolo[5,4- a]pyrrolo[3,4- c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases

Design and synthesis of dihydroindazolo[5,4- a]pyrrolo[3,4- c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases

by Dandu, Reddeppareddy, Zulli, Allison L., Bacon, Edward R., Underiner, Ted, Robinson, Candy, Chang, Hong, Miknyoczki, Sheila, Grobelny, Jennifer, Ruggeri, Bruce A., Yang, Shi, Albom, Mark S., Angeles, Thelma S., Aimone, Lisa D., Hudkins, Robert L.
Published in Bioorganic & medicinal chemistry (15.03.2008)

Get full text

Journal Article

Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituent

Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituent

by Myers, Michael R., He, Wei, Hanney, Barbara, Setzer, Natalie, Maguire, Martin P., Zulli, Allison, Bilder, Glenda, Galzcinski, Helen, Amin, Dilip, Needle, Saul, Spada, Alfred P.
Published in Bioorganic & medicinal chemistry letters (15.09.2003)

Get full text

Journal Article

Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity

Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity

by Guertin, Kevin R, Gardner, Charles J, Klein, Scott I, Zulli, Allison L, Czekaj, Mark, Gong, Yong, Spada, Alfred P, Cheney, Daniel L, Maignan, Sebastian, Guilloteau, Jean-Pierre, Brown, Karen D, Colussi, Dennis J, Chu, Valeria, Heran, Christopher L, Morgan, Suzanne R, Bentley, Ross G, Dunwiddie, Christopher T, Leadley, Robert J, Pauls, Henry W
Published in Bioorganic & medicinal chemistry letters (17.06.2002)

Get full text

Journal Article

Optimization of the β-aminoester class of factor Xa inhibitors. Part 1: P4 and side-chain modifications for improved in vitro potency

Optimization of the β-aminoester class of factor Xa inhibitors. Part 1: P4 and side-chain modifications for improved in vitro potency

by CZEKAJ, Mark, KLEIN, Scott I, CHU, Valeria, LEADLEY, Robert J, DUNWIDDIE, Christopher T, GUERTIN, Kevin R, GARDNER, Charles J, ZULLI, Allison L, PAULS, Henry W, SPADA, Alfred P, CHENEY, Daniel L, BROWN, Karen D, COLUSSI, Dennis J
Published in Bioorganic & medicinal chemistry letters (17.06.2002)

Get full text

Journal Article

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β‑Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β‑Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes

by Trout, Robert E, Zulli, Allison, Mesaros, Eugen, Jackson, Randy W, Boyd, Steven, Liu, Bin, Hamrick, Jodie, Daigle, Denis, Chatwin, Cassandra L, John, Kaitlyn, McLaughlin, Lisa, Cusick, Susan M, Weiss, William J, Pulse, Mark E, Pevear, Daniel C, Moeck, Greg, Xerri, Luigi, Burns, Christopher J
Published in Journal of medicinal chemistry (22.07.2021)

Get full text

Journal Article

PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE

PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE

by ZULLI ALLISON L, HUDKINS ROBERT L
Year of Publication 21.09.2016

Get full text

Patent

경구 전달 베타-락타마제 억제제의 고체 형태 및 이의 용도

경구 전달 베타-락타마제 억제제의 고체 형태 및 이의 용도

by BURNS CHRISTOPHER J, TROUT ROBERT E. LEE, SIMPSON ROBERT, MESAROS EUGEN F, CONDON STEPHEN M, BOYD STEVEN A, ZULLI ALLISON L, DENG YIJUN, ROSEN LAWRENCE
Year of Publication 06.12.2021

Get full text

Patent

Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4 H -indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent

by Hudkins, Robert L., Becknell, Nadine C., Zulli, Allison L., Underiner, Ted L., Angeles, Thelma S., Aimone, Lisa D., Albom, Mark S., Chang, Hong, Miknyoczki, Sheila J., Hunter, Kathryn, Jones-Bolin, Susan, Zhao, Hugh, Bacon, Edward R., Mallamo, John P., Ator, Mark A., Ruggeri, Bruce A.
Published in Journal of medicinal chemistry (26.01.2012)

Get full text

Journal Article

1,4-치환된 피페리딘 유도체

1,4-치환된 피페리딘 유도체

by DANDU REDDEPPA REDDY, WEINBERG LINDA, GOTCHEV DIMITAR B, ZIFICSAK CRAIG A, BECKNELL NADINE C, ZULLI ALLISON L, DORSEY BRUCE D, HUDKINS ROBERT L
Year of Publication 12.03.2018

Get full text

Patent

Correction to Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4 H -indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent

by Hudkins, Robert L., Becknell, Nadine C., Zulli, Allison L., Underiner, Ted L., Angeles, Thelma S., Aimone, Lisa D., Albom, Mark S., Chang, Hong, Miknyoczki, Sheila J., Hunter, Kathryn, Jones-Bolin, Susan, Zhao, Hugh, Bacon, Edward R., Mallamo, John P., Ator, Mark A., Ruggeri, Bruce A.
Published in Journal of medicinal chemistry (26.04.2012)

Get full text

Journal Article

Identification of pyridazin-3-one derivatives as potent, selective histamine H sub(3 receptor inverse agonists with robust wake activity)

Identification of pyridazin-3-one derivatives as potent, selective histamine H sub(3 receptor inverse agonists with robust wake activity)

by Hudkins, Robert L, Aimone, Lisa D, Bailey, Thomas R, Bendesky, Robert J, Dandu, Reddeppa reddy, Dunn, Derek, Gruner, John A, Josef, Kurt A, Lin, Yin-Guo, Lyons, Jacquelyn, Marcy, Val R, Mathiasen, Joanne R, Sundar, Babu G, Tao, Ming, Zulli, Allison L, Raddatz, Rita, Bacon, Edward R
Published in Bioorganic & medicinal chemistry letters (15.09.2011)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[17]